Novo Holdings A/S - Q4 2021 holdings

Add to watchlist

$2.11 Billion is the total value of Novo Holdings A/S's 48 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 18.4% .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
VTI  VANGUARD INDEX FDStotal stk mkt$466,921,000
+8.7%
1,933,9000.0%22.11%
-0.5%
NewEXSCIENTIA PLCads$258,591,000–13,086,600
+100.0%
12.24%–
BAM SellBROOKFIELD ASSET MGMT INCcl a ltd vt sh$176,380,000
+6.6%
2,921,171
-5.6%
8.35%
-2.5%
AAPL SellAPPLE INC$163,165,000
+11.2%
918,879
-11.4%
7.73%
+1.8%
BSX  BOSTON SCIENTIFIC CORP$147,133,000
-2.1%
3,463,5770.0%6.97%
-10.4%
MORF  MORPHIC HLDG INC$97,150,000
-16.3%
2,050,4460.0%4.60%
-23.4%
EWTX  EDGEWISE THERAPEUTICS INC$85,373,000
-8.0%
5,587,2070.0%4.04%
-15.7%
BABA BuyALIBABA GROUP HLDG LTDsponsored ads$59,493,000
+87.1%
500,827
+133.1%
2.82%
+71.2%
CYT  CYTEIR THERAPEUTICS INC$55,035,000
-35.2%
4,840,4130.0%2.61%
-40.7%
NKTX  NKARTA INC$42,886,000
-44.8%
2,793,8640.0%2.03%
-49.5%
MIRM  MIRUM PHARMACEUTICALS INC$39,000,000
-19.9%
2,445,1470.0%1.85%
-26.7%
INGN SellINOGEN INC$36,473,000
-21.6%
1,072,735
-0.6%
1.73%
-28.2%
ALGS  ALIGOS THERAPEUTICS INC$31,035,000
-23.5%
2,614,5630.0%1.47%
-30.0%
FOLD  AMICUS THERAPEUTICS INC$29,570,000
+20.9%
2,560,2110.0%1.40%
+10.7%
RPHM  RENEO PHARMACEUTICALS INC$29,330,000
+14.8%
3,430,3770.0%1.39%
+5.1%
CABO  CABLE ONE INC$27,991,000
-2.7%
15,8730.0%1.32%
-11.0%
VERV BuyVERVE THERAPEUTICS INC$25,809,000
-8.5%
700,000
+16.7%
1.22%
-16.2%
BOLT  BOLT BIOTHERAPEUTICS INC$22,070,000
-61.3%
4,503,9910.0%1.04%
-64.5%
BPMC  BLUEPRINT MEDICINES CORP$21,101,000
+4.2%
197,0000.0%1.00%
-4.7%
NewIO BIOTECH INC$20,979,000–3,277,932
+100.0%
0.99%–
SPRB  SPRUCE BIOSCIENCES INC$20,134,000
-25.8%
4,514,3360.0%0.95%
-32.1%
INSM  INSMED INC$18,955,000
-1.1%
695,8400.0%0.90%
-9.4%
LVTX  LAVA THERAPEUTICS NV$18,300,000
-7.1%
3,327,3120.0%0.87%
-15.0%
VECT  VECTIVBIO HLDG AG$17,293,000
-36.4%
3,522,0190.0%0.82%
-41.7%
MIST  MILESTONE PHARMACEUTICALS IN$16,575,000
+14.7%
2,530,5850.0%0.78%
+5.1%
IOVA  IOVANCE BIOTHERAPEUTICS INC$15,969,000
-22.6%
836,5180.0%0.76%
-29.1%
RCKT BuyROCKET PHARMACEUTICALS INC$13,378,000
-16.2%
612,822
+14.7%
0.63%
-23.4%
SPNE SellSEASPINE HLDGS CORP$11,696,000
-32.4%
858,752
-21.9%
0.55%
-38.1%
GRTX  GALERA THERAPEUTICS INC$11,287,000
-43.3%
2,459,0210.0%0.53%
-48.2%
NewMINERVA SURGICAL INC$10,574,000–2,057,132
+100.0%
0.50%–
KNTE BuyKINNATE BIOPHARMA INC$9,801,000
-14.6%
553,128
+11.0%
0.46%
-21.9%
TMCI BuyTREACE MED CONCEPTS INC$9,328,000
+22.2%
500,421
+76.3%
0.44%
+11.9%
AKUS BuyAKOUOS INC$9,027,000
+9.2%
1,061,990
+49.2%
0.43%
-0.2%
INSP BuyINSPIRE MED SYS INC$8,167,000
+64.7%
35,500
+66.7%
0.39%
+50.6%
LUNG  PULMONX CORP$7,923,000
-10.9%
247,0470.0%0.38%
-18.5%
MQ NewMARQETA INC$7,582,000–441,558
+100.0%
0.36%–
GLTO  GALECTO INC$7,568,000
-15.6%
2,497,7910.0%0.36%
-22.8%
SPRO  SPERO THERAPEUTICS INC$7,507,000
-13.0%
468,9020.0%0.36%
-20.4%
PHVS BuyPHARVARIS N V$7,430,000
+0.0%
516,321
+23.2%
0.35%
-8.3%
ZGNX  ZOGENIX INC$7,191,000
+7.0%
442,5500.0%0.34%
-2.3%
NARI  INARI MED INC$6,591,000
+12.6%
72,2120.0%0.31%
+3.0%
SILK  SILK RD MED INC$6,287,000
-22.6%
147,5570.0%0.30%
-29.0%
CMPI  CHECKMATE PHARMACEUTICALS IN$6,228,000
-27.7%
2,170,1000.0%0.30%
-33.9%
VRNA  VERONA PHARMA PLCsponsored ads$5,115,000
+22.6%
761,2050.0%0.24%
+12.0%
PRAX  PRAXIS PRECISION MEDICINES I$4,925,000
+6.5%
250,0000.0%0.23%
-2.5%
ALNY  ALNYLAM PHARMACEUTICALS INC$4,240,000
-10.2%
25,0000.0%0.20%
-17.6%
AERI  AERIE PHARMACEUTICALS INC$3,897,000
-38.4%
555,1860.0%0.18%
-43.4%
FRLN SellFREELINE THERAPEUTICS HLDGSsponsored ads$3,518,000
-46.5%
1,776,613
-7.9%
0.17%
-50.9%
FSTX ExitF-STAR THERAPEUTICS INC$0–-2,703
-100.0%
-0.00%–
HRMY ExitHARMONY BIOSCIENCES HLDGS IN$0–-40,000
-100.0%
-0.08%–
ANNX ExitANNEXON INC$0–-114,330
-100.0%
-0.11%–
AFIB ExitACUTUS MED INC$0–-255,000
-100.0%
-0.12%–
FLXN ExitFLEXION THERAPEUTICS INC$0–-1,403,370
-100.0%
-0.44%–
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VANGUARD INDEX FDS41Q3 202264.7%
INOGEN INC34Q2 202268.8%
VANGUARD INTL EQUITY INDEX F29Q4 201637.6%
AMICUS THERAPEUTICS INC22Q3 20234.1%
AKEBIA THERAPEUTICS INC21Q3 20204.8%
VERONA PHARMA PLC21Q2 20221.9%
CORVUS PHARMACEUTICALS INC20Q4 20207.1%
INSPIRE MED SYS INC20Q3 20231.8%
CABLE ONE INC19Q3 20239.7%
FLEXION THERAPEUTICS INC19Q3 20214.7%

View Novo Holdings A/S's complete holdings history.

Latest significant ownerships (13-D/G)
Novo Holdings A/S Q4 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cyteir Therapeutics, Inc.August 03, 20231,547,1364.4%
Disc Medicine, Inc.June 28, 20231,090,7724.8%
Galera Therapeutics, Inc.June 28, 20232,100,0004.9%
VectivBio Holding AGSold outMay 26, 202300.0%
LanzaTech Global, Inc.February 17, 202315,814,8458.1%
Bolt Biotherapeutics, Inc.Sold outJanuary 04, 202300.0%
Arcellx, Inc.December 12, 20221,750,0004.0%
MINERVA SURGICAL INCNovember 03, 20221,322,4734.5%
Milestone Pharmaceuticals Inc.October 24, 20221,378,5384.6%
Galecto, Inc.September 30, 20222,497,7919.8%

View Novo Holdings A/S's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D/A2024-03-28
42024-03-25
SC 13D/A2024-03-25
42024-03-20
SC 13D/A2024-03-20
1442024-03-18
42024-03-18
SC 13D/A2024-03-18
1442024-03-14
SC 13D/A2024-03-07

View Novo Holdings A/S's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (2111972000.0 != 2111971000.0)

Export Novo Holdings A/S's holdings

CSVXLS